Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 455

Results For "NAL"

6627 News Found

MFine and LifeCell form JV ‘LifeWell’
Digitisation | July 11, 2022

MFine and LifeCell form JV ‘LifeWell’

LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~


Feeling younger can help us rehabilitate faster : Study
News | July 11, 2022

Feeling younger can help us rehabilitate faster : Study

Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity


Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'
Policy | July 11, 2022

Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'

The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics


Sirio Pharma announces agreement to acquire best formulations
News | July 10, 2022

Sirio Pharma announces agreement to acquire best formulations

The combined company will be able to better serve both our global and regional customers with local production


China medical devices market to surpass $42 billion in 2022: GlobalData
News | July 10, 2022

China medical devices market to surpass $42 billion in 2022: GlobalData

Domestic devices are usually preferred over imported medical devices in the national or regional procurement.


We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
interviews | July 08, 2022

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing


Glenmark launches Sitagliptin and its FDC at affordable price
News | July 08, 2022

Glenmark launches Sitagliptin and its FDC at affordable price

These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


WuXi STA opens Oligonucleotide and Peptide manufacturing facility
News | July 08, 2022

WuXi STA opens Oligonucleotide and Peptide manufacturing facility

Site Enhances New Modality CRDMO Platform Capacity for Customers